Patients in methadone maintenance treatment who inject methadone syrup: A preliminary study

Drug and Alcohol Review

Volumn 19, Issue 4, 2000, Pages 447-450

  Robinson, Geoffrey M ^a,c   Kemp, Robert ^b   Lee, Colin ^a   Cranston, David ^b  

^a Alcohol and Drug Services   (New Zealand)

^b Drugs and Health Development Project   (New Zealand)

^c WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Injecting; Methadone maintenance treatment; Methadone syrup

Indexed keywords

EID: 0034551011     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/713659430     Document Type: Article

References (21)

1. Sellman D, Deering D, Robinson GM. Methadone maintenance treatment: coming of age in New Zealand. NZ Med J 1995;108:128-30.
2. Bedford KR, Nolan SL, Onrust R, Siegers JD. The illicit preparation of morphine and heroin from pharmaceutical products containing codeine: 'homebake' laboratories in New Zealand. Forensic Sci Int 1987;34:197-204.
3. Robinson GM, Dukes PD, Robinson BJ, Cooke RR, Mahoney GN. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend 1993;33:81-6.
4. National protocol for methadone programmes in New Zealand. Wellington Department of Health, Drugs Advisory Committee, 1992.
5. National Protocol for Methadone Treatment in New Zealand, 1996. Wellington: Ministry of Health.
6. Inciardi JA. Methadone diversion: experiences and issues. Rockville, Maryland: National Institute of Drug Abuse, 1977.
7. Spunt B, Hunt DE, Lipton DS, Goldsmith DS. Methadone diversion: a new look.20J. Drug Issues 1986;16:569-83.
8. Lauzon P, Vincelette J, Bruneau J, et al Illicit use of methadone among iv drug users in Montreal. J Subst Abuse Treat 1994;11:457-61.
9. Cherubin CE, Sapira JD. The medical complication of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Int Med 1993;119:1017-28.
10. Scheidegger C, Pietrzak J, Frei R. Disseminated candidiasis after intravenous use of oral methadone. Ann Int Med 1991;115: 576.
11. Pare JAP, Fraser RG, Hogg JC, Howlett JG, Murphy SB. Pulmonary 'mainline' granulomatosis: talcosis of intravenous methadone abuse. Medicine 1979;58:229-39.
12. Pare JP, Cote G, Fraser RS. Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis 1989;139:233-41.
13. Bainborough AR, Jericho KWF. Cor pulmonale secondary to talc granulomata in the lungs of a drug addict. Can Med Ass J 1970;103:1297-8.
14. Launchbury AP, Drake J, Seager H. Misuse of temazepam. Br Med J 1992;305:252-3.
15. Fox R, Beeching NJ, Morrison C, Ruben S, Garvey T. Misuse of temazepam. Br Med J 1992;305:353.
16. Hingorani AD, Ainsworth RW. Pulmonary micro-embolism and temazepam. Br Med J 1993;307: 623-4.
17. Sunjic S, Howard J. 'Non-injectables' : methadone syrup and benzodiazepine injection by methadone-maintained clients. Drug Alcohol Rev 1996;15: 245-50.
18. Darke S, Ross M, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Dep 1996;43:191-8.
19. Lintzeris N, Lenné M, Ritter A. Methadone injecting in Australia: a tale of two cities. Addiction 1999;94:1175-8.
20. Loimer N, Presslich O, Grunberger J, Linzmayer L. Combined naloxone/methadone preparations for opiate substitution therapy. J Subst Abuse Treat 1991; 8:157-60.
21. FarrellM, Ward J, Mattick R, et al. Methadone maintenance treatment in opiate dependence: a review. Br Med J 1994;309:997-1001.